Evidence map›Paper›PMID 40479404›Full record

ArticleBiomedical materials & devices (New York, N.Y.)2022

A Novel Antipathogenic Agent for Nonwoven Fabric.

Sydney Simpson, Chelsey McMinn, Sherry M Van Mondfrans, Jackson Hendry, Sean Ronayne, Stephen Dewhurst, Changyong Feng, B Sonny Bal, Ryan M Bock, Bryan J McEntire

Abstract read
In one paragraph

Article in Biomedical materials & devices (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sydney SimpsonQuidelOrtho Corporation, 100 Indigo Creek Dr., Rochester, NY 14620 USA.
Chelsey McMinnSINTX Technologies, Inc., Salt Lake City, UT 84119 USA.ORCID 0000-0001-9878-738X
Sherry M Van MondfransSINTX Technologies, Inc., Salt Lake City, UT 84119 USA.ORCID 0000-0003-3485-5835
Jackson HendrySINTX Technologies, Inc., Salt Lake City, UT 84119 USA.ORCID 0000-0002-3088-4789
Sean RonayneSINTX Technologies, Inc., Salt Lake City, UT 84119 USA.ORCID 0000-0003-3678-5893
Stephen DewhurstDepartment of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642 USA.
Changyong FengDepartment of Biostatistics and Computational Biology, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642 USA.ORCID 0000-0002-4432-1565
B Sonny BalSINTX Technologies, Inc., Salt Lake City, UT 84119 USA.ORCID 0000-0002-9615-8632
Ryan M BockSINTX Technologies, Inc., Salt Lake City, UT 84119 USA.ORCID 0000-0002-3422-7751
Bryan J McEntireSINTX Technologies, Inc., Salt Lake City, UT 84119 USA.ORCID 0000-0002-7612-9789

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical-grade masks and N95 respirators containing non-woven fibers are designed to prevent the spread of airborne diseases. While they effectively trap respiratory droplets and aerosols, they cannot lyse entrapped pathogens. Embedded antimicrobial agents such as silver, copper, zinc, iodine, peptides, quaternary ammonium salts, or nanoparticles have been used to overcome this limitation. However, their effectiveness remains debatable because these materials can be toxins, allergens, irritants, and environmental hazards. Recently, silicon nitride (Si

Indexed as

AntiviralNonwoven fabricPad-dry-cureSARS-CoV-2Silicon nitride

Identifiers

PMID40479404
PMCPMC9299416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.